New Indications and Dosage Forms for 2006

See also: New Drug Approvals for 2006

February 10, 2006

FDA Approves Rituxan Plus CHOP or other Anthracycline-Based Chemotherapy Regimens for First-Line Treatment of Diffuse Large B-Cell Non-Hodgkin's Lymphoma

May 1, 2006

Nexium Approved for Children 12 to 17 For Short-Term Treatment of GERD

July 31, 2006

October 6, 2006

FDA Approves Risperdal to Treat Irritability Associated with Autism

October 11, 2006

FDA Approves Avastin in Combination With Chemotherapy for First-Line Treatment of Most Common Type of Lung Cancer

October 12, 2006

FDA Approves Nexium for the Treatment of Zollinger-Ellison Syndrome

October 23, 2006

FDA Approves AstraZeneca's Seroquel For Bipolar Depression Treatment

November 16, 2006

FDA Approves Herceptin for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer

New indications and dosage forms archive

Recently Approved

Nuvaxovid
Nuvaxovid (COVID-19 Vaccine, Adjuvanted) is a protein-based, non-MRNA vaccine...
Emrelis
Emrelis (telisotuzumab vedotin) is a first-in-class, c-Met protein directed...
Avmapki Fakzynja Co-Pack
Avmapki Fakzynja Co-Pack (avutometinib and defactinib, co-packaged) is a kinase...

More drug approvals